Effects of SGLT-2 Inhibitors on Body Composition in Heart Patients
Author Information
Author(s): De La Flor José C., Coto Morales Blanca, Basabe Elena, Rey Hernandez María, Zamora González-Mariño Rocío, Rodríguez Tudero Celia, Benites Flores Irwing, Espinoza Carlos, Cieza Terrones Michael, Cigarrán Guldris Secundino, Hernández Vaquero Jesús
Primary Institution: Hospital Central de la Defensa Gómez Ulla, Madrid, Spain
Hypothesis
What are the effects of SGLT-2 inhibitors on body composition and fluid status in cardiovascular rehabilitation patients?
Conclusion
SGLT-2 inhibitors help reduce body fat and extracellular volume without losing lean body mass in heart failure patients.
Supporting Evidence
- Patients treated with SGLT-2 inhibitors lost more weight than those who were not treated.
- SGLT-2 inhibitors significantly reduced extracellular water and body fat mass.
- Patients on SGLT-2 inhibitors did not lose lean body mass during the study.
- Significant reductions in systolic and diastolic blood pressure were observed in the SGLT-2 inhibitor group.
- NT-proBNP levels improved significantly in patients treated with SGLT-2 inhibitors.
Takeaway
This study shows that a type of medicine called SGLT-2 inhibitors can help heart patients lose fat and water weight without losing muscle.
Methodology
This was a retrospective, observational longitudinal cohort study analyzing body composition and fluid status using bioelectrical impedance analysis over 12 weeks.
Potential Biases
Potential bias due to the observational nature and disparity in group sizes.
Limitations
The study had a small sample size and was observational with a short follow-up period.
Participant Demographics
71.4% male, mean age 66.9 years, with high comorbidity rates including 32.8% having type 2 diabetes.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website